No Picture
Uncategorized

Research Associate – PacBio – San Diego, CA

The ideal candidate will have working knowledge and experience in molecular biology techniques, automated systems, next-generation sequencing methods and…From PacBio – Thu, 02 Dec 2021 02:26:56 GMT – View all San Diego, CA jobsClick here […]

No Picture
Uncategorized

Principal Scientist – PacBio – San Diego, CA

The successful candidate will have experience in PCR and molecular biology techniques, a working knowledge of automated systems and experience in next…From PacBio – Thu, 02 Dec 2021 02:26:29 GMT – View all San Diego, […]

No Picture
News

PhaseBio Announces Publication of Interim Results from Pivotal REVERSE-IT Phase 3 Trial of Bentracimab in NEJM Evidence

MALVERN, Pa. & SAN DIEGO–(BUSINESS WIRE)—- $PHAS #NEJM–PhaseBio Announces Publication of Interim Results from Pivotal REVERSE-IT Phase 3 Trial of Bentracimab in NEJM Evidence Click here to view original post… […]

No Picture
News

Inhibrx Receives FDA Orphan-Drug Designation for INBRX-109 in Chondrosarcoma

SAN DIEGO: SAN DIEGO, Dec. 1, 2021 /PRNewswire/ — Inhibrx, Inc. (Nasdaq: INBX), a biotechnology company with four clinical programs in development and a strong emerging pipeline, today announced that the U.S. Food and Drug Administration, or FDA, has granted orphan-drug designation for INBRX-109 for the treatment of chondrosarcoma. "We… Click here to view original post… […]

No Picture
News

Halozyme Announces Janssen Receives U.S. FDA Approval of DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) in Combination with Carfilzomib and Dexamethasone for Patients with Multiple Myeloma After First or Subsequent Relapse

SAN DIEGO: SAN DIEGO, Dec. 1, 2021 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced Janssen Biotech, Inc. (Janssen) received U.S. Food and Drug Administration (FDA) approval of DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) in combination with Kyprolis® (carfilzomib) and dexamethasone (Kd) for the treatment of adult patients with relapsed… Click here to view original post… […]

No Picture
News

Quest Diagnostics Now Offers Biocept’s Liquid Biopsy Test for Lung Cancer, Expanding its Menu of Advanced Cancer Diagnostics

SECAUCUS, N.J. and SAN DIEGO: SECAUCUS, N.J. and SAN DIEGO, Dec. 1, 2021 /PRNewswire/ — Physicians in the United States can now order the liquid biopsy-based Target Selector™ NGS Lung Panel test directly from Quest Diagnostics (NYSE: DGX), the nation’s leading provider of diagnostic information services. Developed by Biocept, Inc…. Click here to view original post… […]

No Picture
News

The Lancet Psychiatry Publishes Results from ADVANCE Study Evaluating Pimavanserin Treatment for Negative Symptoms of Schizophrenia

SAN DIEGO–(BUSINESS WIRE)–Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) announced today that The Lancet Psychiatry published results from the Phase 2 ADVANCE study. ADVANCE was an international, 26-week, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of adjunctive pimavanserin treatment in outpatients with moderate-to-severe predominant negative symptoms of schizophrenia who had… Click here to view original post… […]

No Picture
News

Regulus Therapeutics Announces Presentation at the First Annual Rare & Genetic Kidney Disease Drug Development Summit

SAN DIEGO: SAN DIEGO, Dec. 1, 2021 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced a presentation at the first annual Rare & Genetic Kidney Disease Drug Development Summit. In the… Click here to view original post… […]

No Picture
News

Helixmith Announces 50% Enrollment in its Clinical Trial for COVID-19, involving TADIOS

SAN DIEGO: SAN DIEGO, Dec. 1, 2021 /PRNewswire/ — Helixmith Co., Ltd. has announced that 50 subjects have been enrolled in its double-blind placebo controlled COVID-19 clinical trial involving 100 subjects. The investigational product is called TADIOS, which is a proprietary botanical treatment. The clinical trial is being conducted in… Click here to view original post… […]